This compound is an Fmoc-protected derivative of L-norleucine, a building block used in solid-phase peptide synthesis. Its significance lies in its role as a research reagent for incorporating norleucine residues into synthetic peptides.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 77284-32-3
Fmoc-L-Norvaline
pharmaceutical intermediate
Fmoc-L-lysine
pharmaceutical intermediate
Nalpha-Fmoc-L-lysine hydrochloride
pharmaceutical intermediate
N2-[(9H-Fluoren-9-ylmethoxy)carbonyl]-D-lysine hydrochloride
pharmaceutical intermediate
Fmoc-L-tert-leucine
research compound
N-Fmoc-L-Glutamine
research compound
Fmoc-D-proline
research compound
Fmoc-N-methyl-D-leucine
research compound
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoic acid
VCFCFPNRQDANPN-IBGZPJMESA-N
CCCC[C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13